Submission Documentation for Sterilization Process Validation - A Comprehensive View of Content for an Approvable CMC Section

Instructor: Colin Davis
Product ID: 701926
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Feb-2012

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

In this sterility assurance documentation webinar, you will learn specifically what information is required in sterility assurance documentation for injectable drug products and how to present it in CTD format. You will understand differences in content for terminal sterilization versus aseptic processes.

Why Should You Attend:

Having a plan for gathering and compiling appropriate sterility assurance documentation to be included in a global marketing application is essential for injectable drug products. In this session we will provide an overview of current regulatory guidance and compendial requirements associated with sterilization validation and control of microbial quality. We will review what information is needed, what level of detail is included, and how to present the documentation in CTD format.

Attendees will also learn what data and information need to be included in your submission for different approaches (terminal sterilization vs. aseptic processes) to manufacturing a sterile drug product. We will review information needed in support of the sterilization and depyrogenation of container closure components, filter validation, heat penetration and distribution studies, and container closure integrity testing.

In addition the speaker will also focus on the need for periodic requalification of sterile processes and review requirements for use of parametric release in lieu of sterility testing for batch release, which substantially shortens the release timeline.

Learning Objectives:

Knowing what data and information are needed to construct an approvable sterility assurance section for an injectable dosage form, and to understand how this information is compiled within the CMC section of a global marketing application.

Areas Covered in the Seminar:

  • Global regulatory guidance and other relevant sources for sterility assurance.
  • Recent changes in regulatory guidance.
  • Sterility assurance content for marketing applications.
  • Differences in content for terminal sterilization versus aseptic processes.
  • Expectations for requalification of sterile processes.
  • Use of parametric release in lieu of sterility testing at release.
  • Use of container closure integrity in lieu of sterility testing on stability.
  • Validation documentation for microbial quality test methods.
  • Potential pitfalls due to insufficient sterility assurance documentation.

Who Will Benefit:

This webinar will provide valuable assistance to all personnel in:

  • Pharmaceutical development project teams
  • Regulatory Affairs
  • Quality Assurance
  • Analytical and formulation development
  • Emerging pharmaceutical companies

Instructor Profile:

Colin Davis, has over 30 years of experience in the pharmaceutical industry, primarily in regulatory affairs and project management. After completing his Bachelor of Science degree in Chemistry from Miami University, Colin joined The Upjohn Company, where he remained employed with Pharmacia and Upjohn, Pharmacia Corporation, and Pfizer, Inc. After leaving Pfizer, Inc. in 2005, he gained additional experience in the generic pharmaceutical industry working as an Associate Director of Regulatory Affairs for Hospira, Inc. and The Perrigo Co. Throughout his career Colin has held positions in analytical methods development, cGMP compliance, project management, and CMC regulatory affairs. In his position as Director of CMC Regulatory Affairs for Pfizer, Inc., Colin managed regulatory scientists in the preparation of CMC registration documentation, participated on global development teams, and spearheaded various initiatives for improving organizational performance and global quality standards.

Follow us :
Latin America: Regulatory Compliance Requirements for Life Science Products
Upcoming In-person Seminars by EX-FDA OFFICIALS

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed